KnowHow: The FDB Blog

Healthcare Supply chain

Repair Hospital Supply Chain Data Breaks to Protect Patient Safety

Corporate Perspective, Transformational Change, Information Systems
Monday, February 5, 2018 by Lee Ann McWhorter

Today’s medical device data is far more likely to be inaccurate, unclear, and unreliable. And that’s entirely unacceptable when you consider the vast range of users who rely on this knowledge to identify, source, manage, document, track, and bill for millions of device options. Read more...

Comments (0)

Artificial Intelligence in Health IT – Catalyst for Change?

Corporate Perspective, Information Systems, Transformational Change
Wednesday, January 3, 2018 by Josh Young

We recently interviewed FDB's Director of Software Engineering Joshua Young about the application of artificial intelligence in healthcare. What follows are highlights from that interview. Read more...

Comments (0)

FDA's Biosimilar ID Requirements Fly in the Face of Cost-Cutting Aspirations

Corporate Perspective, Government, Standards
Friday, November 10, 2017 by Tom Bizzaro, RPh

Curiously, the FDA seems to be undercutting its own cost savings efforts through its support of a rule that would require unique non-proprietary names with four-character suffixes for biosimilar products. The problem is this proposed naming convention is simply not necessary and could do more harm than good. Read more...

Comments (0)
Pharmacists Comparing Labels

Drug Labeling Inconsistencies Abound Regarding Sulfites As Preservatives

Corporate Perspective, Information Systems
Tuesday, August 22, 2017 by Helena Dummler, PharmD

Our society’s focus on natural and organic products that promote health has directed scrutiny to chemicals used as preservatives. What is the issue with preservatives? Read more...

Comments (0)
Baseball sweet spot

Medical Device Data Transparency Could Help Health Systems Hit the Elusive Supply Chain "Sweet Spot"

Corporate Perspective, Transformational Change, Information Systems
Thursday, July 13, 2017 by Lee Ann McWhorter

Any baseball player will tell you how difficult it is to ensure that the ball hits the “sweet spot” on the bat. But their troubles pale in comparison to health system supply chain or value analysis committees. Read more...

Comments (0)
View more

Don't Miss a Single Post!

Be notified about new FDB Blog posts as they are published by submitting the information below. (If you are already an FDB Customer in North America, you are automatically receiving blog updates by email and do not need to sign up.)

*
*
*

Blogger Spotlight

Lee Ann McWhorter

Lee Ann McWhorter
Strategic Alliances Director

Josh Young
Director, Software Development

Tom Bizzaro

Tom Bizzaro, RPh
VP, Health Policy

Helena Dummler

Helena Dummler, PharmD
Clinical Pharmacist

Ray Pedden

Ray Pedden
Strategy and Innovation, CCI

Nick Ratto

Nick Ratto, PharmD
Manager, Consumer Drug Info

Christine Cheng

Christine Cheng, PharmD
Clinical Pharmacist

Pat Lupinetti

Patrick Lupinetti, JD
Senior VP and Editorial Director

Brad Engels

Brad Engels
Associate Product Manager

Dewey Howell

Dewey Howell, MD, PhD
VP, Clinical Applications

Doris Yee, PharmD

Doris Yee, PharmD
Clinical Pharmacist